Open Therapeutic Sequences - Prior Art Publication

LEGAL DISCLAIMER: This is THEORETICAL COMPUTATIONAL RESEARCH only. Not peer reviewed. Not medical advice. All predictions require experimental validation. PRIOR ART PUBLICATION - DEFENSIVE DISCLOSURE This dataset contains computationally engineered therapeutic protein sequences published as Prior Art to prevent patent enclosure and ensure public access to potential treatments for: Alzheimer's disease (anti-amyloid-β, anti-tau antibodies) Parkinson's disease (anti-α-synuclein antibodies) ALS (anti-SOD1 antibodies) Engineering modifications: Supercharging for aggregation resistance Glycan shielding for reduced immunogenicity Angiopep-2 fusion for blood-brain barrier crossing License: OpenMTA + CC BY-SA 4.0 LEGAL DISCLAIMER: This is THEORETICAL COMPUTATIONAL RESEARCH only. Not peer reviewed. Not medical advice. All predictions require experimental validation. No patents may be filed on these sequences or derivatives.